BBIO
Price
$38.57
Change
+$0.17 (+0.44%)
Updated
May 2 closing price
Capitalization
7.32B
88 days until earnings call
ROIV
Price
$11.48
Change
-$0.10 (-0.86%)
Updated
May 2 closing price
Capitalization
8.19B
52 days until earnings call
Ad is loading...

BBIO vs ROIV

Header iconBBIO vs ROIV Comparison
Open Charts BBIO vs ROIVBanner chart's image
BridgeBio Pharma
Price$38.57
Change+$0.17 (+0.44%)
Volume$3.17M
Capitalization7.32B
Roivant Sciences
Price$11.48
Change-$0.10 (-0.86%)
Volume$8.77M
Capitalization8.19B
BBIO vs ROIV Comparison Chart
Loading...
BBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ROIV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BBIO vs. ROIV commentary
May 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BBIO is a StrongBuy and ROIV is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
May 04, 2025
Stock price -- (BBIO: $38.57 vs. ROIV: $11.48)
Brand notoriety: BBIO and ROIV are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BBIO: 100% vs. ROIV: 121%
Market capitalization -- BBIO: $7.32B vs. ROIV: $8.19B
BBIO [@Biotechnology] is valued at $7.32B. ROIV’s [@Biotechnology] market capitalization is $8.19B. The market cap for tickers in the [@Biotechnology] industry ranges from $306.3B to $0. The average market capitalization across the [@Biotechnology] industry is $2.29B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BBIO’s FA Score shows that 1 FA rating(s) are green whileROIV’s FA Score has 0 green FA rating(s).

  • BBIO’s FA Score: 1 green, 4 red.
  • ROIV’s FA Score: 0 green, 5 red.
According to our system of comparison, ROIV is a better buy in the long-term than BBIO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BBIO’s TA Score shows that 5 TA indicator(s) are bullish while ROIV’s TA Score has 6 bullish TA indicator(s).

  • BBIO’s TA Score: 5 bullish, 4 bearish.
  • ROIV’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, ROIV is a better buy in the short-term than BBIO.

Price Growth

BBIO (@Biotechnology) experienced а +6.24% price change this week, while ROIV (@Biotechnology) price change was +4.27% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.30%. For the same industry, the average monthly price growth was +8.07%, and the average quarterly price growth was -4.75%.

Reported Earning Dates

BBIO is expected to report earnings on Jul 31, 2025.

ROIV is expected to report earnings on Aug 18, 2025.

Industries' Descriptions

@Biotechnology (+4.30% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ROIV($8.19B) has a higher market cap than BBIO($7.32B). BBIO YTD gains are higher at: 40.561 vs. ROIV (-2.959). ROIV has higher annual earnings (EBITDA): 4.1B vs. BBIO (-436.83M). ROIV has more cash in the bank: 5.15B vs. BBIO (681M). ROIV has less debt than BBIO: ROIV (100M) vs BBIO (1.73B). BBIO has higher revenues than ROIV: BBIO (222M) vs ROIV (123M).
BBIOROIVBBIO / ROIV
Capitalization7.32B8.19B89%
EBITDA-436.83M4.1B-11%
Gain YTD40.561-2.959-1,371%
P/E RatioN/A1.97-
Revenue222M123M180%
Total Cash681M5.15B13%
Total Debt1.73B100M1,731%
FUNDAMENTALS RATINGS
BBIO: Fundamental Ratings
BBIO
OUTLOOK RATING
1..100
43
VALUATION
overvalued / fair valued / undervalued
1..100
4
Undervalued
PROFIT vs RISK RATING
1..100
78
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
38
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BBIOROIV
RSI
ODDS (%)
Bearish Trend 3 days ago
76%
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
80%
Bearish Trend 3 days ago
74%
Momentum
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 3 days ago
64%
MACD
ODDS (%)
Bullish Trend 3 days ago
87%
Bullish Trend 3 days ago
69%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
77%
Bullish Trend 3 days ago
62%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 3 days ago
63%
Advances
ODDS (%)
Bullish Trend 3 days ago
78%
Bullish Trend 5 days ago
71%
Declines
ODDS (%)
Bearish Trend 19 days ago
84%
Bearish Trend 3 days ago
74%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
67%
Bullish Trend 3 days ago
61%
Aroon
ODDS (%)
N/A
Bearish Trend 3 days ago
83%
View a ticker or compare two or three
Ad is loading...
BBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ROIV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
KEMQ19.390.76
+4.08%
KraneShares Em Mkts Cnsmr Tech ETF
XJR37.290.80
+2.19%
iShares ESG Select Scrn S&P Small-CapETF
VTWV131.002.75
+2.14%
Vanguard Russell 2000 Value ETF
PIZ41.860.55
+1.33%
Invesco DW Developed Markets Momt ETF
SCHI22.24-0.06
-0.27%
Schwab 5-10 Year Corp Bd ETF

BBIO and

Correlation & Price change

A.I.dvisor indicates that over the last year, BBIO has been loosely correlated with ARGX. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if BBIO jumps, then ARGX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BBIO
1D Price
Change %
BBIO100%
+0.44%
ARGX - BBIO
46%
Loosely correlated
+1.53%
AXON - BBIO
44%
Loosely correlated
+1.14%
ARRY - BBIO
43%
Loosely correlated
-2.52%
PMN - BBIO
43%
Loosely correlated
-1.54%
ROIV - BBIO
41%
Loosely correlated
-0.86%
More

ROIV and

Correlation & Price change

A.I.dvisor indicates that over the last year, ROIV has been loosely correlated with IMVT. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if ROIV jumps, then IMVT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ROIV
1D Price
Change %
ROIV100%
-0.86%
IMVT - ROIV
59%
Loosely correlated
-0.63%
ACLX - ROIV
54%
Loosely correlated
+0.03%
KYMR - ROIV
49%
Loosely correlated
+2.11%
CRNX - ROIV
49%
Loosely correlated
+0.72%
DYN - ROIV
49%
Loosely correlated
-1.08%
More